Articles and recorded conversations tagged dementia diagnosis. Choose an item below to read or watch the discussion in context.
Livestreams on Dementia Diagnosis
Live Q&A sessions from Neurofeedback & Chill where Dr. Hill demonstrates protocols, answers viewer questions, and explores dementia diagnosis applications in real-time with QEEG examples and brain training discussions.
Latest Sessions
There's Finally a Blood Test for Alzheimer's. Should You Get It?
For decades, getting a real answer about Alzheimer's meant a spinal tap, a PET scan, or waiting until the symptoms were obvious. As of 2025 there's a fourth option: a single blood draw. The FDA cleared the first one in May, and by August you could order it from a national lab. In this video we break down what the test actually measures, who it's really for (and who it's not), the caveats nobody mentions, and the one question it can't touch - how your brain is actually functioning right now. 🧠 KEY TAKEAWAYS: • The FDA cleared the first blood test for Alzheimer's: the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio (Fujirebio) on May 16, 2025. It's a diagnostic aid, not a screening test. • It's intended for adults 55+ who already have signs or symptoms of cognitive decline, evaluated in a clinical setting, NOT for healthy, asymptomatic people who feel fine and want to peek around the corner. • p-tau217 is the standout blood biomarker. The test's ratio agrees with amyloid PET about 92% of the time for positives and about 97% for negatives. • A positive result means amyloid is present - it does NOT by itself mean you have Alzheimer's. Amyloid shows up in cognitively normal people too, and kidney function can shift the number. • The blood test measures pathology: is excess amyloid there? A QEEG brain map measures function - how is your brain actually working? Those are different questions, and function is the trainable one. KEY RESEARCH CITED: • U.S. FDA (May 16, 2025). First blood test cleared to aid Alzheimer's diagnosis: Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio (Fujirebio Diagnostics). In vitro diagnostic, 510(k), Breakthrough Device. Validation: multicenter study of 499 plasma samples from cognitively impaired adults vs amyloid PET/CSF with 91.7% positive percent agreement, 97.3% negative percent agreement, under 20% indeterminate. • Palmqvist et al., Nature Medicine (2025)" SEPARATE multicenter study of 1,767 participants with cognitive symptoms on a fully automated plasma p-tau217 platform; ~85% accuracy in primary care. DOI 10.1038/s41591-025-03622-w (PMID 40205199). • Ashton et al., JAMA Neurology (2024): plasma p-tau217 immunoassay establishes p-tau217 as the standout blood biomarker for Alzheimer's pathology. DOI 10.1001/jamaneurol.2023.5319. • Labcorp (Aug 18, 2025): nationwide launch of the FDA-cleared plasma p-tau217/β-amyloid 1-42 ratio test. • U.S. FDA (Aug 2025): subcutaneous lecanemab autoinjector (Leqembi IQLIK) approved for at-home maintenance dosing; lecanemab (Leqembi) and donanemab (Kisunla) approved for MCI/mild AD. RESOURCES: 📞 Book a free consultation: https://calendly.com/drhill1 🧠 Peak Brain Institute: https://peakbraininstitute.com 🗺️ QEEG Brain Mapping: https://peakbraininstitute.com/brain-mapping 📖 Dr. Hill's books: https://www.peakbrainpress.com #Alzheimers #BloodTest #pTau217 #BrainHealth #QEEG #DrAndrewHill #NeurofeedbackAndChill #Neuroscience #Neurofeedback #Dementia #BrainMapping #Amyloid #BrainAwarenessMonth
NFB & Chill: Can Music Shield Your Brain from Dementia?( plus EEG Biomarker Secrets)
Can music habits protect your brain? And can EEG brainwaves help spot dementia early? We break down new research (listening vs playing), EEG biomarkers (AD vs FTD vs LBD), and where neurofeedback fits. 👉 Book a free consult call: https://calendly.com/drhill1 In this video we unpack two fresh threads in aging research— 1. how music engagement (listening & playing) relates to lower dementia risk, and 2. the EEG brainwave “fingerprints” that may help distinguish dementia types earlier (Alzheimer’s vs FTD vs Lewy body). We’ll decode the science without the jargon, show how these findings fit into brain health & neurofeedback, and take your live questions. Expect practical takeaways, a little myth-busting, and a fun “scientist-with-secrets” vibe. What we’ll cover • The new music–dementia findings: listening vs playing—what looks most protective and why. • How music may build cognitive reserve (multi-network activation, attention/emotion/memory effects). • EEG 101 for dementia: alpha slowing, posterior rhythms, connectivity, and what emerging AI models are finding. • Where neurofeedback or PBM fits (and where it doesn’t): possibilities, limits, and next steps. • Live Q&A Who this is for: curious minds, caregivers, clinicians-in-training, brain hackers, and anyone who loves the idea that playlists and brainwaves might actually tell us something helpful. ⚠️ Disclaimer: This stream is for education and is not medical advice. Talk with your clinician before making changes. ⸻ 🧠 References: • Jaffa, E., Wu, Z., Owen, A., Zaw Phyo, A. A., Woods, R. L., Orchard, S. G., Chong, T. T.-J., Shah, R. C., Murray, A., & Ryan, J. (2025). What is the association between music-related leisure activities and dementia risk? A cohort study. International Journal of Geriatric Psychiatry. Advance online publication. https://doi.org/10.1002/gps.70163 • Jungrungrueang, T., Chairat, S., Rasitanon, K., Limsakul, P., & Charupanit, K. (2025). Translational approach for dementia subtype classification using convolutional neural network based on EEG connectome dynamics. Scientific Reports, 15(1), Article 17331. https://doi.org/10.1038/s41598-025-02018-7 ⸻ 📅 Live 6 PM Pacific Mondays Subscribe and hit the bell 🔔 for weekly science‑backed brain updates. ⸻ 🧠 RESOURCES 👉 Book a free consult: https://calendly.com/drhill1 👉 $250 off QEEG Brain Mapping: https://peakbraininstitute.com/special/ ⸻ Relevant Topics: #Neurofeedback #EEG #Dementia #Alzheimers #BrainHealth #MusicTherapy #CognitiveReserve #Neuroscience #Aging #Longevity #FTD #LewyBodyDementia #Attention #Focus #Neurofeedback #QEEG #BrainTraining #ExecutiveFunction #Neuroplasticity #BrainOptimization #PeakBrain